News

Clinical Trial Participation Tied to Improved Breast Cancer Outcomes


 

FROM A SYMPOSIUM SPONSORED BY THE SOCIETY OF SURGICAL ONCOLOGY

Another attendee pointed out that the Rapid Reporting System sends out an alert if cancer patients are not completing therapy. Dr. Dooley said the system was not in place for the entire study period.

Dr. Dooley and his coauthors reported no relevant conflicts of interest.

Pages

Recommended Reading

Trastuzumab Benefit Persists at 4 Years in HER2-Positive Breast Cancer
MDedge Hematology and Oncology
FDA Grants Hearing on Withdrawal of Bevacizumab Approval
MDedge Hematology and Oncology
Eribulin Extends Survival of Women With Heavily Pretreated Breast Cancer
MDedge Hematology and Oncology
Plastic Surgery Groups Remove Cancer-Implant Webinar After Complaints
MDedge Hematology and Oncology
Optimal Therapy Elusive for Many Ovarian Cancer Patients With Medicare
MDedge Hematology and Oncology
Techniques Compared for Breast Tumor Detection
MDedge Hematology and Oncology